Publications by authors named "Jose Maria Ribera"

Claim this Profile
I
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib.
Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Jose-Maria Ribera

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial.
Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Jose-Maria Ribera

Leukemia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib.
Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Jose-Maria Ribera

Cancer Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies.
Marcos de Lima, Alice Di Rocco, Jose-Maria Ribera

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Elias Jabbour, Hagop M Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica T Leonard, Jose-Maria Ribera

JAMA· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
Mi Kwon, Gloria Iacoboni, Juan Luis Reguera, Lucía López Corral, Rafael Hernani Morales, Jose Maria Ribera

Haematologica· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EHA Research Roadmap: Malignant Lymphoid Diseases.
Martin Dreyling, Marc André, Nicola Gökbuget, Hervé Tilly, Mats Jerkeman, José Maria Ribera

Hemasphere· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
José Luis Piñana, Lourdes Vázquez, Rodrigo Martino, Rafael de la Cámara, Anna Sureda, José-María Ribera

Leuk Lymphoma· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse.
Maribel Forero-Castro, Adrián Montaño, Cristina Robledo, Alfonso García de Coca, José Luis Fuster, Jordi Ribera, José-María Ribera

Diagnostics (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab.
Jose-Maria Ribera, Eulalia Genescà, Jordi Ribera

Ther Adv Hematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
Marta Sobas, Rebeca Rodriguez-Veiga, Edo Vellenga, Monika Paluszewska, Javier De la Serna, José María Ribera

Eur J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of stem cell transplantation in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Jose-Maria Ribera, Jordi Ribera, Eulalia Genescà

Ther Adv Hematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia.
Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires, Anne Papaioannou, Eric Hatterer, José María Ribera

Mol Cancer Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Ricardo Sanchez, Rosa Ayala, Rafael Alberto Alonso, María Pilar Martínez, Jordi Ribera, José-María Ribera

Ann Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.
Nicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, Adele K Fielding, Anjali Advani

Haematologica· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria].
Ana Villegas, Beatriz Arrizabalaga, Santiago Bonanad, Enrique Colado, Anna Gaya, José-María Ribera

Med Clin (Barc)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.
Wyndham H Wilson, Jacoline E C Bromberg, Maryalice Stetler-Stevenson, Seth M Steinberg, Lourdes Martin-Martin, Jose Maria Ribera

Haematologica· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome.
Carmen Muñiz, Lourdes Martín-Martín, Antonio López, Blanca Sánchez-González, Antonio Salar, José María Ribera

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
José Luis Piñana, Jaime Sanz, Alessandra Picardi, Christelle Ferrá, Rodrigo Martino, José-María Ribera

Haematologica· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, José-María Ribera

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, José-María Ribera

Lancet Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
Juan José Lahuerta, Maria Victoria Mateos, Joaquin Martínez-López, Laura Rosiñol, Anna Sureda, José María Ribera

J Clin Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.
Juan Berenguer, Pilar Miralles, José María Ribera, Rafael Rubio, Eulalia Valencia

J Acquir Immune Defic Syndr· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
Eva González-Barca, Eva Domingo-Domenech, Francisco Javier Capote, Jose Gómez-Codina, Antonio Salar, Jose-María Ribera

Haematologica· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
José Rodríguez, Eulogio Conde, Antonio Gutiérrez, Reyes Arranz, Marcos Gandarillas, Jose Maria Ribera

Eur J Haematol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis